相关实验视频
Updated: Jul 22, 2026

05:19
Surgical Models of Gastroesophageal Reflux with Mice
Published on: August 25, 2015
梅丽莎 officinalis L. 通过减弱 NF-κB 和 MAPK 介导的老鼠炎症来预防反流性食道炎
Hye Rin Kim1, Yoo Yeon Na2, Byung Kil Choo3
1Department of Crop Science and Biotechnology, Jeonbuk National University, 54896, Jeonju, Republic of Korea.
Journal of ethnopharmacology
|March 3, 2026
概括
梅丽莎 officinalis L. 提取物通过减少炎症和保护食道组织来保护反流性食道炎. 这项研究支持其用于炎症性食道疾病的使用.
科学领域:
- 药理学和民族植物学
- 胃肠病学 胃肠病学
- 分子生物学分子生物学
背景情况:
- 梅丽莎官L. (香) 传统上用于胃肠道问题.
- 对于其在反流性食道炎中的保护作用的证据有限.
研究的目的:
- 评估M. officinalis L.提取物对逆流食道炎的保护作用.
- 调查潜在的抗炎作用机制.
主要方法:
- 在体外抗氧化和抗炎测定 (氧化抑制,炎症媒介表达).
- 对NF-κB和MAPK信号通路的分析 (西式涂抹).
- 在生体内对患有逆流食道炎的老鼠进行研究,评估食道损伤和分子标记.
主要成果:
- M. officinalis L. 提取物表现出剂量依赖的抗氧化活性,并减少了氧化的产生.
- 提取物抑制了NF-κB和MAPK通路,降低了COX-2和iNOS的调节.
- 在体内,提取物减轻了食道粘膜损伤,抑制了MAPK激活,减少了促炎细胞因子,并恢复了紧密结合蛋白.
结论:
- M. officinalis L. 提取物通过调节NF-κB/MAPK信号来减轻反流食道炎.
- 提取物有助于在食道炎症条件下保持粘膜的完整性.
- 这些发现支持M. officinalis L.对食道健康的民族药理学相关性.
相关概念视频
NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Gastroesophageal Reflux Disease
Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...

